Stifel analysts maintained a positive outlook on MaxLinear shares (NASDAQ:MXL), reiterating a Buy rating and a price target ...

Stifel analysts reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ:BCAX), maintaining a $47.00 price target. Trading ...

The race for AI supremacy has taken an unexpected twist as Chinese AI startup DeepSeek’s latest AI model, which is both ...

Keokuk High School coach Matt McGhghy lamented the possibility that being ranked is a jinx for the Chiefs girls basketball ...

Plby Group Inc (PLBY) stock saw a decline, ending the day at $1.81 which represents a decrease of $-0.04 or -2.16% from the prior close of $1.85. The stock opened at $1.84 and touched a low of $1.72 ...

With capacity declines driving more freight market gains than demand in 2025, FedEx Freight’s spin-off and march to more ...

In a report released today, Benjamin Nolan from Stifel Nicolaus maintained a Buy rating on CSX (CSX – Research Report), with a price target of ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

After a painful crash early this season, Mikaela Shiffrin announced her return to the racecourse before the end of January.

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.